MycoLogics, Inc. Continues to Expand Antifungal Intellectual Property Portfolio

MycoLogics, Inc., an innovative biotechnology company specializing in the development of novel antifungal drugs and therapeutic and prophylactic vaccines, today announced the receipt of patent 6,716,625, awarded by the U.S. Patent and Trademark Office, for the discovery of compositions and methods related to fungal histidine kinases and the...

Continue to MycoLogics, Inc. Continues to Expand Antifungal Intellectual Property Portfolio on PR Web (The Free Wire Service) Medical Infectious Diseases.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz